Given that cancer cells can hijack a physiological survival mechanism and exploit it for their benefits11, we measured cell survival following Dox application in non-transformed control and ASS1-deficient skin fibroblasts biopsied from healthy patients and those with CTLN-1, respectively. This evidence concerns the gene ASS1 and cancer.